Muralidharan et al. showed that in TERT-promoter mutant glioma (81% IDH-wildtype), this mutation can be detected in 63% of cases in plasma cfDNA employing digital droplet PCR (ddPCR) [89]. Here, IDH1 is linked to central nervous system cancer.